TGCT is a rare, non-malignant tumor that develops inside or near joints. TGCT is caused by dysregulation of the CSF1 gene leading to overproduction of CSF1.

A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared thanks to a breakthrough drug.

Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors. Now, researchers at University of California San Diego School of Medicine ...

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the formation of a malignant tumor.

Immunohistochemistry on thyroid tumor samples demonstrated the diagnostic utility of multiple aptamers in identifying TSHR-positive pathology. This research advances aptamer-based diagnostics and ...

Emergency department (ED) presentations are associated with higher cancer mortality. This study aimed to investigate the prevalence, frequency, and risk factors in Australian patients diagnosed ...

Teen cancer survivor raises thousands for brain tumor awareness Walker was diagnosed with medulloblastoma, a malignant tumor that primarily affects children, after a routine visit to the eye ...

A lab-designed molecule developed and extensively studied could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.

Abstract e23510 Background: Giant cell tumor of bone (GCTB) is a locally recurrent, rarely metastasizing tumor. However, GCTB can undergo malignant transformation. Malignancy in GCTB (mGCTB) may be ...

Trump Jr alleges ‘cover-up’ after 2022 clip of Biden saying he has cancer resurfaces - Ernst doubles down on Medicaid comment with sarcastic video ‘apology’ Ricky Gervais takes credit for ...